Carlyle Group Inc (The)

Carlyle Group Inc (The)

CG

Get informed when a big investor buys or sells

+ Follow
Market Cap$16.35B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Carlyle Group Inc (The)Carlyle Group Inc (The)29.93.08%7%3.82

Earnings Call Q3 2025

October 31, 2025 - AI Summary

Strong Financial Performance: Carlyle reported Fee-Related Earnings (FRE) of $312 million for Q3 2025, up 12% year-over-year, contributing to a year-to-date total of $946 million, indicating a solid growth trajectory with a projected full-year FRE growth of approximately 10% (up from a prior outlook of 6%).
Record AUM and Inflows: Total Assets Under Management (AUM) reached a record $474 billion, a 7% increase year-to-date. The firm delivered organic inflows of $17 billion in Q3 and nearly $60 billion in inflows over the past 12 months, significantly surpassing the prior year and highlighting strong demand in credit and global wealth sectors.
Market Resilience Amid Challenges: Despite a complex and somewhat challenging macro environment, Carlyle noted resilience in the global economy, with healthy consumer spending and balanced economic fundamentals. The firm stated that its data shows no broad deterioration in credit quality, with favorable market conditions expected to continue into 2026.

Exclusive for Stockcircle Pro members

Sign upSign Up
$60.33

Target Price by Analysts

42.8% upsideCarlyle Group(The) Target Price DetailsTarget Price
$-10.96

Current Fair Value

125.9% downside

Overvalued by 125.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$16.35 Billion
Enterprise Value$28.57 Billion
Dividend Yield$1.40 (3.08%)
Earnings per Share$2.25
Beta1.89
Outstanding Shares359,200,000

Return

Return on Equity7.41%ROE
Return on Assets1.83%
Return on Invested Capital3.49%

Valuation & Multiples

P/E Ratio29.86P/E Ratio
PEG-14.8PEG
Price to Sales3.84Price to Sales
Price to Book Ratio2.11Price to Book Ratio
Enterprise Value to Revenue6.96
Enterprise Value to EBIT27.76
Enterprise Value to Net Income52
Total Debt to Enterprise0.52
Debt to Equity2.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 8, 2026
EPS Estimate
$1.02
Average shareholder expectation
Revenue Estimate
$1.03 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 4, 2026
EPS Estimate
$0.92
Average shareholder expectation
Revenue Estimate
$947.53 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4118 17.57%
Total Calls4,807,442 40.00%
Total Puts1,979,800 144.21%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %60.86% 2.75%
Total Invested$10.60B 21.73%
Investors Holding627 22.00%

ESG Score

No data

About Carlyle Group Inc (The)

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the official 'revenue estimates' for all tax legislation, directly influencing corporate tax structures, capital investment credits, and the overall tax burden, which are critical to Carlyle's investment returns and fund structures.

Finance

This is the most powerful committee influencing Carlyle. It controls taxation (e.g., corporate tax rates, carried interest, capital gains), trade, and entitlement spending, all of which directly impact corporate valuations and Carlyle's profitability.

Appropriations

This committee's allocation of federal spending directly determines cash flow for defense programs, scientific research, and infrastructure projects, impacting the order books and valuations of many companies in which Carlyle invests.

Agriculture, Nutrition, and Forestry

This committee's oversight of the CFTC and definition of digital commodities directly impacts the massive derivatives/futures market and emerging cryptocurrency space, both highly relevant to financial firms like Carlyle.

Health, Education, Labor, and Pensions

This committee directly impacts sectors where Carlyle invests (healthcare, education) through drug approval oversight (FDA/NIH) and influences labor costs across all portfolio companies through labor laws and regulations.

Judiciary

This committee's oversight of antitrust laws and intellectual property is crucial for M&A activity, a core function of private equity. Its decisions on mega-mergers directly impact Carlyle's ability to execute and exit investments.

Armed Services

Carlyle invests in defense contractors; this committee's authorization of the annual NDAA and funding decisions for the Department of Defense directly determine the revenue and R&D opportunities for its portfolio companies in this sector.

Banking, Housing, and Urban Affairs

This committee directly regulates the financial system, including the SEC, bank capital requirements, cryptocurrency, and real estate markets. As an investment firm, Carlyle's core operations, fundraising, and investment vehicles (e.g., BDCs, real estate funds) are directly impacted by these regulations.

Commerce, Science, and Transportation

This committee's broad jurisdiction over industries like 'Big Tech,' telecommunications, aerospace, and transportation directly impacts many sectors where Carlyle invests, through regulations on privacy, antitrust, and safety.

Energy and Natural Resources

Carlyle frequently invests in energy, mining, and natural resource companies; this committee's policies on energy, leasing, and critical minerals directly impact the valuation and operational environment of these assets.